García-Sáenz M C, Arias-Puente A, Rodríguez-Caravaca G, Andrés Alba Y, Bañuelos Bañuelos J
Departamento de Oftalmología, Hospital Universitario Fundación Alcorcón, Madrid, España.
Arch Soc Esp Oftalmol. 2010 Aug;85(8):263-7. doi: 10.1016/j.oftal.2010.07.006. Epub 2010 Oct 30.
To estimate the incidence of endophthalmitis after cataract surgery and to describe the main epidemiological and clinical data, as well as the role of intracameral antibiotics.
A cross-sectional descriptive study was conducted on patients who underwent cataract surgery in a public hospital over an 11-year period. An ocular infection database was used to report endophthalmitis occurrences and to collect the clinical features. Qualitative variables are described with their frequency distribution and qualitative variables, with the mean and the standard deviation.
From January 1999 to December 2009, 15.173 patients underwent cataract surgery. A total of 43 patients suffered from postoperative endophthalmitis, giving an overall infection rate of 0.28% (95% CI: 0.20-0.36%). Among the 43 cases, there were 19 men and 24 women with a mean age of 78.5. Other clinical parameters evaluated were as follows: 25.58% were diabetic, 44.18% had some degree of immunosuppression and there were complications with posterior capsular tears in 18.6%. As regards antibiotic prophylaxis, 2 groups were considered: the first one did not receive intracameral antibiotic (8,099 patients) and the second group received intracameral cefuroxime (7,074 patients). There were 39 endophthalmitis in the first group with an infection incidence of 0.48% and 4 endophthalmitis in the second group with an infection incidence of 0.056%. The relative risk (RR) after-before cefuroxime was 0.12 (0.04-0.33) with P<0.05.
The incidence of endophthalmitis after cataract surgery in an 11-year period was lower than 0.3%. Almost half of the patients had a higher systemic risk. Intracameral cefuroxime resulted in nearly a 9-fold reduction in the rate of infection.
评估白内障手术后眼内炎的发生率,描述主要的流行病学和临床数据,以及前房内抗生素的作用。
对一家公立医院11年间接受白内障手术的患者进行横断面描述性研究。使用眼部感染数据库报告眼内炎的发生情况并收集临床特征。定性变量用频率分布描述,定量变量用均值和标准差描述。
1999年1月至2009年12月,15173例患者接受了白内障手术。共有43例患者发生术后眼内炎,总体感染率为0.28%(95%可信区间:0.20 - 0.36%)。在这43例病例中,男性19例,女性24例,平均年龄78.5岁。评估的其他临床参数如下:25.58%为糖尿病患者,44.18%有一定程度的免疫抑制,18.6%有后囊膜破裂并发症。关于抗生素预防,分为两组:第一组未接受前房内抗生素(8099例患者),第二组接受前房内头孢呋辛(7074例患者)。第一组有39例眼内炎,感染发生率为0.48%,第二组有4例眼内炎,感染发生率为0.056%。头孢呋辛使用前后的相对风险(RR)为0.12(0.04 - 0.33),P<0.05。
11年间白内障手术后眼内炎的发生率低于0.3%。几乎一半的患者有较高的全身风险。前房内使用头孢呋辛使感染率降低了近9倍。